Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy, Gastroenterology, vol.126, pp.1750-1758, 2004. ,
URL : https://hal.archives-ouvertes.fr/inserm-00133134
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study, J. Hepatol, vol.50, 2009. ,
Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure, Gut, pp.64-1314, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01263140
Evolution of Hepatitis B Serological Markers in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy, Clinical Infectious Diseases, vol.45, issue.9, pp.45-1221, 2007. ,
DOI : 10.1086/522173
Rates and determinants of hepatitis B ???e??? antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus, AIDS, vol.29, issue.15, pp.1963-1973, 2015. ,
DOI : 10.1097/QAD.0000000000000795
Hepatitis B surface antigen declines and clearance during longterm tenofovir therapy in patients coinfected with HBV and HIV, J. Infect. Dis, vol.206, pp.974-980, 2012. ,
Performance of the DiaSorin LIAISON?? anti-HBs II for the detection of hepatitis B surface antibodies: Comparison with the Abbott Architect anti-HBs assay, Journal of Clinical Virology, vol.50, issue.4, pp.297-302, 2011. ,
DOI : 10.1016/j.jcv.2011.01.009
Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients, J. Viral Hepat, vol.18, pp.61-69, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00851726
Mathematical modeling provides kinetic details of the human immune response to vaccination, Front, Cell. Infect. Microbiol, vol.4 ,
A mathematical model predicting anti-hepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B, Clinical and Experimental Immunology, vol.175, issue.1, pp.121-126, 1999. ,
DOI : 10.1016/0168-8278(89)90013-5
Antibody Responses during Hepatitis B Viral Infection, PLoS Computational Biology, vol.54, issue.7 ,
DOI : 10.1371/journal.pcbi.1003730.s006
URL : http://doi.org/10.1371/journal.pcbi.1003730
van 't Riet, Modeling of the bacterial growth curve, Appl. Environ. Microbiol, pp.56-1875, 1990. ,
Five-year on-treatment efficacy of lamivudine-, tenofovir-and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients, J. Viral Hepat, vol.19, 2012. ,
Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals, PLoS ONE, vol.48, issue.4 ,
DOI : 10.1371/journal.pone.0061297.t003
Long-term outcome in Caucasian patients with chronic hepatitis B virus infection after HBsAg seroclearance, Liver International, vol.56, issue.1, pp.140-147, 2015. ,
DOI : 10.1016/j.jhep.2011.09.024
Long-term entecavir therapy results in falls in serum hepatitis B surface antigen levels and seroclearance in nucleos(t)ide-naïve chronic hepatitis B patients, J. Viral Hepat, vol.21, pp.802-808, 2014. ,
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France, Digestive Diseases and Sciences, vol.49, issue.Suppl, pp.10-10620, 1007. ,
DOI : 10.1002/hep.22885
Clinical outcomes after spontaneous and nucleos(t)ide analogue-treated HBsAg seroclearance in chronic HBV infection, Alimentary Pharmacology & Therapeutics, vol.46, issue.12, pp.1311-1318, 2016. ,
DOI : 10.1159/000074999
Fine mapping of virusneutralizing epitopes on hepatitis B virus PreS1, Virology, pp.270-279, 2000. ,
Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells, Hepatology, vol.11, issue.Pt. 2, pp.52-875, 2010. ,
DOI : 10.1038/nm1244
Evidence for ongoing low-level viremia in patients with chronic hepatitis B receiving long-term nucleos(t)ide analog therapy, Hepatology, pp.60-1093, 2014. ,
Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable, J. Hepatol, vol.63, 2015. ,
Large surface proteins of hepatitis B virus containing the pre-s sequence, J. Virol, pp.52-396, 1984. ,
Antibody-directed complement-mediated cytotoxicity to hepatocytes from patients with chronic hepatitis B, Clinical & Experimental Immunology, vol.55, issue.2, pp.227-232, 1995. ,
DOI : 10.3181/00379727-186-2-RC1
Mathematical model of the antibody response to hepatitis B vaccines: Implications for reduced schedules, Vaccine, vol.25, issue.18, 2007. ,
DOI : 10.1016/j.vaccine.2007.01.012
Trial Comparing 3 Strategies of Vaccination Against the Virus of Hepatitis B in HIV-Infected Patients) Group, Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial, JAMA Intern. Med, pp.176-603, 2016. ,
Response to vaccination against hepatitis B virus with a schedule of four 40-?g doses in cirrhotic patients evaluated for liver transplantation: factors associated with a response, Transplant. Proc, vol.44, pp.1499-1501, 2012. ,
HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration, J. Hepatol, vol.46, pp.635-644, 2007. ,
Longterm persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers, Vaccine, pp.22-607, 2004. ,
Impact of Highly Active Antiretroviral Therapy (HAART) on the Natural History of Hepatitis B Virus (HBV) and HIV Coinfection: Relationship between Prolonged Efficacy of HAART and HBV Surface and Early Antigen Seroconversion, Clinical Infectious Diseases, vol.45, issue.5, pp.45-624, 2007. ,
DOI : 10.1086/520752
Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections, J. Hepatol, vol.55, pp.53-60, 2011. ,
Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of ,